"life science" - Knowledge Bank Results
Life sciences venture capital firm Sofinnova Partners has sold its portfolio company Corvidia Therapeutics to Novo Nordisk for $2.1bn.
Spanish early stage investment house Ysios Capital has hit €155m for its third life science fund - and could go as high as €200m for the vehicle.
Protera, an AI-driven startup designing and developing new proteins, has closed a $5.6m Series A financing led by European life sciences venture capital major Sofinnova Partners.
Real asset alternative investment specialist Harrison Street has expanded its European asset management team with two new hires.
Private equity firm Thoma Bravo has acquired Exostar, a secure business collaboration platform for the aerospace and defence, life sciences and healthcare industries.
Blackstone has hired former US Food and Drug Administration commissioner Mark McClellan as its latest senior advisor.
UK real estate investment house Yoo Capital has hit a first close for its £400m-targeting sophomore investment fund.
Cowen Healthcare Investments has raised $493m for its third flagship investment vehicle, beating its initial $400m target.
Private equity giant Blackstone has pulled in more than $4.2bn for its latest life sciences fund, putting it within a whisker of reaching its fundraising goal.
Mérieux Equity Partners and Korys have launched a new healthcare and nutrition venture capital platform, saying Covid-19 has raised public and government awareness of the importance of biologics research.